Results 101 to 110 of about 161,325 (240)

Protecting Intermediate Innovations When Ideas Are Scarce: Patents or Secrecy?

Journal of Economics &Management Strategy, EarlyView.
ABSTRACT Patenting an intermediate research innovation can lead to competition for the development of a final commercial innovation and potentially induce wasteful duplicative R&D efforts. This study examines the effects of different protection strategies and patent life on the incentives to protect an intermediate innovation by considering a two‐stage
Bonwoo Koo, Jangho Yang, Brian D. Wright
wiley   +1 more source

Polish Antitrust Legislation and Case Law Review 2010 [PDF]

Yearbook of Antitrust and Regulatory Studies, 2011
The article presents key developments in Polish antitrust legislation and case law of 2010. Regarding legislation, the article focuses on a new group exemption for agreements on motor vehicle distribution; also provided is a general characterisation of ...
Agata Jurkowska-Gomułka
doaj  

We Value Your Privacy: Behavior‐Based Pricing Under Endogenous Privacy

Journal of Economics &Management Strategy, EarlyView.
ABSTRACT We study a duopoly model of behavior‐based pricing in which consumers can either disclose or hide their data. We contrast two data policies. Under an open data policy, disclosed data is shared with all firms. In the unique equilibrium, all consumers disclose, and firms price discriminate, leading to welfare losses from inefficient poaching ...
Friederike Heiny, Tianchi Li, Michel Tolksdorf   +2 more
wiley   +1 more source

Competition Enforcement and Accounting for Intangible Capital

The Journal of Finance, EarlyView.
ABSTRACT Antitrust laws mandate review of mergers and acquisitions (M&As) that exceed an asset size threshold based on accounting standards that exclude most intangible capital. We show that this exclusion leads to thousands of intangible‐intensive M&As being nonreportable. Acquirers in nonreportable deals achieve higher equity values and price markups,
JOHN D. KEPLER, CHARLES G. MCCLURE, CHRISTOPHER R. STEWART   +2 more
wiley   +1 more source

Package on Actions for Damages Based on Breaches of EU Competition Rules: Can One Size Fit All? [PDF]

Yearbook of Antitrust and Regulatory Studies, 2014
On 17 April 2014, the Proposal for a Directive on antitrust damages actions was accepted by the European Parliament and sent to the EU Council of Ministers for final approval.
Sofia Oliveira Pais, Anna Piszcz
doaj  

The Growing Influence of Economics and Economists on Antitrust: An Extended Discussion [PDF]

Over the past two to three decades economics has played an increasingly important role in the development of U.S. antitrust enforcement and policy. This essay first reviews the major facets of U.S. antitrust enforcement and next reviews the ways in which
White, Lawrence J.
core   +1 more source

Innovation, Licensing, and Competition: Evidence From Genetically Engineered Crops

The Journal of Industrial Economics, EarlyView.
ABSTRACT We provide a novel empirical analysis of the role of technology licensing, between competitors, for genetically engineered (GE) traits in the US seed industry. We extend the standard differentiated‐product Bertrand pricing model to include trait licensing, which permits us to recover marginal costs and (otherwise unobserved) royalty rates ...
GianCarlo Moschini, Edward D. Perry
wiley   +1 more source

Antitrust Policy and Environmental Protection [PDF]

We examine the effects of antitrust policy (the prohibition of a input price discrimination) when an emission tax is used for environmental protection. We show that antitrust policy reduces pollution emission and improves social welfare.
Hajime Sugeta, Shigeru Matsumoto
core  

Defenses to International Antitrust Suits: An Aggregate Approach [PDF]

, 1981
Part I of this Comment will discuss briefly the cases in which the defenses have been asserted. Part I will examine the underlying policies of each defense.
Acampora, Anthony C.
core   +1 more source

The Determinants of Negotiated Pharmaceutical Prices

The Journal of Industrial Economics, EarlyView.
ABSTRACT We focus on the determinants of pharmaceutical drug prices. Using data from the Brazilian pharmaceutical market, we find large variations in drug prices across buyers, drug classes, and time periods. Our estimation results provide evidence that transaction‐specific determinants between buyers and sellers (e.g., transaction volume, buyer's ...
Ralph B. Siebert, Sebastian Linde, Brandon Norton   +2 more
wiley   +1 more source